US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

SITE Centers Corp.

11.50

+0.09000.79%

Post-market: 11.500.00000.00%19:52 EDT

Volume:1.33M

Turnover:15.23M

Market Cap:603.12M

PE:1.11

High:11.56

Open:11.52

Low:11.36

Close:11.41

Loading ...

Overview Company News Filings

Xenetic Biosciences, Inc. Presents Positive Preclinical Data Underscoring the Potential of DNase I as an Adjunctive Treatment to Enhance Immunotherapeutic Responses

ACCESS Newswire

Press Release: Indaptus Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Corporate Update

NextCure Provides Business Update and Reports Full Year 2024 Financial Results

Adicet Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Company Progress

Press Release: Molecular Partners Reports Highlights from Q4 2024 and Key Financials for Full Year 2024

Zymeworks Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Fate Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates

CERo Therapeutics Holdings, Inc. to Present Data at the Society for Immunotherapy of Cancer Spring Scientific March 12-14

Aura Biosciences Announces Additional Data from Ongoing Phase 1 Trial in Non-Muscle Invasive Bladder Cancer to be Presented as a Late-Breaking Abstract at the 40th Annual European Association of Urology Congress

Adicet Announces Poster Presentations Highlighting ADI-270 Data at the Society for Immunotherapy of Cancer (SITC) 2025 Spring Scientific Meeting

SITE Centers Stock Declines on Q4 OFFO & Revenue Estimate Miss

SITE Centers Is Maintained at Overweight by Piper Sandler

Site Centers Corp reports results for the quarter ended December 31 - Earnings Summary

Stock Track | SITE Centers Corp. Plummets 6.84% in Pre-Market on Disappointing Q4 Results and Weak Outlook

Here's What Key Metrics Tell Us About SITE Centers Corp. (SITC) Q4 Earnings

Xenetic Biosciences, Inc. Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer (SITC) Spring Scientific 2025 Cell Therapy Meeting

ACCESS Newswire

Stock Track | SITE Centers Corp. Plunges 6.46% in Pre-Market on Disappointing Q4 Results and Outlook

IMUNON Reports 2024 Financial Results and Provides Business Update Highlighting Significant Progress Towards the Initiation of a Pivotal Phase 3 Study

SITE CENTERS CORP. (SITC) Misses Q4 FFO and Revenue Estimates

SITE Centers Q4 FFO $0.16 Misses $0.22 Estimate, Sales $32.87M Miss $66.78M Estimate

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/SITC/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SITC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"SITC\",,,,,undefined,":{"symbol":"SITC","market":"US","secType":"STK","nameCN":"SITE Centers Corp.","latestPrice":11.5,"timestamp":1750104000000,"preClose":11.41,"halted":0,"volume":1327575,"hourTrading":{"tag":"盘后","latestPrice":11.5,"preClose":11.5,"latestTime":"19:52 EDT","volume":262248,"amount":3015852.07,"timestamp":1750117928464},"delay":0,"floatShares":52249855,"shares":52444898,"eps":10.323074,"marketStatus":"Not Yet Opened","change":0.09,"latestTime":"06-16 16:00:00 EDT","open":11.52,"high":11.56,"low":11.36,"amount":15229773.12555,"amplitude":0.017528,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":10.323074,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1750147200000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":11.41,"aum":0,"dividendRate":0.045217,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":11.5,"preClose":11.5,"latestTime":"19:52 EDT","volume":262248,"amount":3015852.07,"timestamp":1750117928464},"volumeRatio":1.383058,"impliedVol":0.3341,"impliedVolPercentile":0.759},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"SITC\",,,,,undefined,":{"symbol":"SITC","floatShares":52249855,"roa":"0.65%","roe":"42.51%","lyrEps":9.805489,"volumeRatio":1.383058,"shares":52444898,"dividePrice":0.52,"high":11.56,"amplitude":0.017528,"preClose":11.41,"low":11.36,"week52Low":10.455,"pbRate":"1.16","psRate":"2.65","week52High":64.44,"institutionHeld":0.9524,"latestPrice":11.5,"eps":10.323074,"divideRate":0.045217,"volume":1327575,"delay":0,"ttmEps":10.323074,"open":11.52,"prevYearClose":15.29,"prevWeekClose":11.41,"prevMonthClose":11.92,"prevQuarterClose":12.84,"fiveDayClose":12.05,"twentyDayClose":12.5,"sixtyDayClose":12.8},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SITC\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2519396918","title":"Xenetic Biosciences, Inc. Presents Positive Preclinical Data Underscoring the Potential of DNase I as an Adjunctive Treatment to Enhance Immunotherapeutic Responses","url":"https://stock-news.laohu8.com/highlight/detail?id=2519396918","media":"ACCESS Newswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519396918?lang=en_us&edition=fundamental","pubTime":"2025-03-13 20:30","pubTimestamp":1741869000,"startTime":"0","endTime":"0","summary":"Data presented at the Society for Immunotherapy of Cancer  Spring Scientific 2025 Cell Therapy Meeting. Findings demonstrate that by degrading neutrophil extracellular traps , DNase I not only facilitates increased T cell infiltration but also restores T cell functionality, paving the way for more effective cancer treatment strategies. FRAMINGHAM, MA / ACCESS Newswire / March 13, 2025 / Xenetic Biosciences, Inc.  , a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers, today announced the presentation of preclinical data investigating the potential of co-administration of deoxyribonuclease I  with chimeric antigen receptor  T cells in a syngeneic B16 melanoma murine model of lung metastasis.The poster titled, \"DNase I Intervention Enhances CAR-T Cell Therapy in Solid Tumors by Targeting Neutrophil Extracellular Traps in Metastatic Melanoma,\" was presented on behalf of the Company by Alexey Stepanov, PhD, Institute","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/xenetic-biosciences-inc-presents-positive-123000628.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4552","SITC","XBIOW","IE00BYTNYN87.SGD","BK4509","BK4535","01698","TME","LU2039709279.SGD","BK4548","BK4565","LU0359202008.SGD","BK4526","BK4231","BK4108","BK4022","BK4563","BK4139","IE00B12V2V27.USD","SG9999011746.SGD","BK4080","BK4230","BK4571","LU0359201612.USD","CAR","XBIO","IE00BYQNZ168.SGD","BK4531","LU1023057109.AUD"],"gpt_icon":0},{"id":"2519386248","title":"Press Release: Indaptus Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2519386248","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519386248?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:30","pubTimestamp":1741865400,"startTime":"0","endTime":"0","summary":"Indaptus Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Corporate Update. -- Company Achieves Key Clinical Milestone with more than 20 Patients. Enrolled in Weekly Dosing Cohort of Phase 1 Trial of Decoy20. -- Pharmacodynamic immune activation biomarker and pharmacokinetics profiles. in initial data sets appear to meet or exceed initial expectations. -- Early signs of potential benefit emerge with some patients demonstrating. Jeffrey Meckler, Chief Executive Officer of Indaptus, commented, \"We continue to make significant progress in our Phase 1 trial of Decoy20, and enrolling more than 20 patients in the weekly dosing cohort marks an important milestone. We are particularly encouraged by the emerging clinical data, with some patients in this cohort demonstrating stable disease - an early sign that Decoy20's immune-modulating approach may be having a meaningful impact. With a favorable safety profile observed so far, we are focused on efficiently a","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4606","BK4139","NLR","INDP","LENZ","BK4080","BK4231","SITC"],"gpt_icon":0},{"id":"2517132651","title":"NextCure Provides Business Update and Reports Full Year 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2517132651","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517132651?lang=en_us&edition=fundamental","pubTime":"2025-03-07 05:05","pubTimestamp":1741295100,"startTime":"0","endTime":"0","summary":"Cash of approximately $68.6 million expected to fund operations into the second half of 2026. BELTSVILLE, Md., March 06, 2025  -- NextCure, Inc. , a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class, and best-in-class therapies to treat cancer, today provided a business update and reported full year 2024 financial results.“In 2024 we reprioritized our resources to advance our antibody-drug conjugate  program and recently completed cohort 1 of the Phase 1 study evaluating LNCB74 as a potential therapeutic for treating multiple cancers. We look forward to additional progress in 2025, including initiating backfill cohorts in the second half of the year,” said Michael Richman, NextCure’s president and CEO.Presented preclinical data from LNCB74  at the Society of Immunotherapy of Cancer  annual meeting in November 2024 to highlight its potential as a therapeutic for treating multiple solid tumor indications.Preclinical data for NC181 , a ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nextcure-provides-business-reports-full-210500630.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NXTC","BK4126","SITC","BK4080","OI","BK4231","BK4139"],"gpt_icon":0},{"id":"2517911392","title":"Adicet Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Company Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2517911392","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517911392?lang=en_us&edition=fundamental","pubTime":"2025-03-07 05:01","pubTimestamp":1741294860,"startTime":"0","endTime":"0","summary":"Phase 1 clinical trial of ADI-001 in autoimmune diseases ongoing; on track to report preliminary clinical data from lupus nephritis  patient cohort in 1H25. Additional LN clinical data and preliminary clinical data from other autoimmune patient cohorts anticipated in 2H25. Initiation of ADI-001 Phase 1 clinical trial patient enrollment in systemic lupus erythematosus , systemic sclerosis , idiopathic inflammatory myopathy  and stiff person syndrome  expected in 2Q25; anti-neutrophil cytoplasmic autoantibody  associated vasculitis  patient enrollment expected to be initiated in 2H25. Continuing to advance phase 1 trial of ADI-001 in autoimmune diseases. In November 2024, Adicet announced the dosing of the first patient in the Phase 1 trial evaluating ADI-001 in LN. Enrollment for SLE, SSc, IIM, and SPS patients is expected to commence in the second quarter of 2025, with the initiation of AAV patient enrollment anti","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adicet-bio-reports-fourth-quarter-210100654.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2065732104.USD","PRGS","BK4080","BK4231","SITC","CAR","BK4077","IIM","BK4230","ACR","ACET","BK4022","BK4139","BK4110","BK4097","SLE"],"gpt_icon":0},{"id":"2517666118","title":"Press Release: Molecular Partners Reports Highlights from Q4 2024 and Key Financials for Full Year 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2517666118","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517666118?lang=en_us&edition=fundamental","pubTime":"2025-03-07 05:00","pubTimestamp":1741294800,"startTime":"0","endTime":"0","summary":"-- DLL3 targeting Radio-DARPin MP0712 to enter first-in-human study in 2025,-- Strategic partnership with Orano Med on Radio-DARPins now expanded to ten. -- MP0533 Phase 1/2a clinical data show improved response rate and depth in. ongoing cohort, additional dosing optimization planned; data expected. and short-term deposits at end of 2024, expected to support operations. \"Molecular Partners has made significant progress through 2024, setting us up for a number of key value inflection points. The potential of our Radio-DARPins is now well recognized in the field. In addition, we are advancing our next-generation immuno-oncology programs, including multispecific and Switch-DARPin T cell engagers\", said Patrick Amstutz, Ph.D., Chief Executive Officer of Molecular Partners.The Investigational New Drug  application for MP0712, a  Pb Radio-DARPin therapy  candidate targeting the tumor-associated protein delta-like ligand 3  and co-developed with Orano Med, is in preparation. Dialogue with th","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756325.SGD","BK4109","BK4080","IE00BMG7P926.USD","IE00BMG7P694.USD","LU1093756168.USD","BK4539","SWCH","LU2463526074.USD","BK4139","BK4231","BK4513","SITC","BK4566","IE00BMG7P819.SGD","MOLN","IE00BMG7P587.USD","BK4116","ASH","TRP","TAT","BK4144"],"gpt_icon":0},{"id":"2517921680","title":"Zymeworks Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2517921680","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517921680?lang=en_us&edition=fundamental","pubTime":"2025-03-06 05:05","pubTimestamp":1741208700,"startTime":"0","endTime":"0","summary":"First-in-human global studies initiated for ZW191, an antibody-drug conjugate (ADC) engineered to target folate receptor- (FR) and ZW171, a bispecific 2 + 1 T cell engager (TCE) targeting mesothelinAc","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/05/3037747/0/en/Zymeworks-Provides-Corporate-Update-and-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","PK","ET","BK4561","BTC","BK4590","SITC","BK4218","ADC","BK4585","BK4144","BK4231","BK4588","BK4080","BK4181"],"gpt_icon":0},{"id":"2517792973","title":"Fate Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2517792973","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517792973?lang=en_us&edition=fundamental","pubTime":"2025-03-06 05:01","pubTimestamp":1741208460,"startTime":"0","endTime":"0","summary":"Phase 1 Dose Expansion Initiated for FT819 Off-the-Shelf CAR T-cell Product Candidate with Fludarabine-free Conditioning in Moderate-to-Severe SLE. Completed Type D Meeting with FDA to Enable FT819 Off-the-Shelf CAR T-cell Dose Expansion in Additional B Cell-mediated Autoimmune Diseases. First FT819 Off-the-Shelf CAR T-cell Patient Treated without Conditioning Chemotherapy as Add-on to Maintenance Therapy in SLE. Phase 1 Dose Expansion Initiated for SLE using Flu-free Conditioning Regimen. Based on clinical data from the first three patients treated with FT819 in its ongoing multi-center, Phase 1 clinical trial for moderate-to-severe systemic lupus erythematosus  , the Company has initiated dose expansion in up to 10 patients at 360 million cells. The dose expansion stage is designed to evaluate the safety and efficacy of a fludarabine -free conditioning regimen, consisting of either bendamustine alone or cyclophosphamide alone, followed by a single dose of FT819. The Company is also a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fate-therapeutics-reports-fourth-quarter-210100391.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","LU2463526074.USD","SITC","FATE","BK4112","CAR","IE00B66KJ199.SGD","BK4022","IE00B19Z4B17.USD","BK4077","IE0031619046.USD","LU2065731478.USD","BK4109","IE00B7SZL793.SGD","IIM","SLE","BK4006","CRS","BK4230","BK4231","BK4080","ASH","TRAC"],"gpt_icon":0},{"id":"2517991147","title":"CERo Therapeutics Holdings, Inc. to Present Data at the Society for Immunotherapy of Cancer Spring Scientific March 12-14","url":"https://stock-news.laohu8.com/highlight/detail?id=2517991147","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517991147?lang=en_us&edition=fundamental","pubTime":"2025-03-05 21:15","pubTimestamp":1741180500,"startTime":"0","endTime":"0","summary":"New poster to highlight preclinical data of CER-1236 in ovarian cancer SOUTH SAN FRANSCISCO, Calif., March  05, 2025  (GLOBE NEWSWIRE) --  CERo Therapeutics Holdings, Inc., (Nasdaq: CERO) (“CERo” or t","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/05/3037386/0/en/CERo-Therapeutics-Holdings-Inc-to-Present-Data-at-the-Society-for-Immunotherapy-of-Cancer-Spring-Scientific-March-12-14.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4231","BK4080","SITC"],"gpt_icon":0},{"id":"2516877986","title":"Aura Biosciences Announces Additional Data from Ongoing Phase 1 Trial in Non-Muscle Invasive Bladder Cancer to be Presented as a Late-Breaking Abstract at the 40th Annual European Association of Urology Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2516877986","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516877986?lang=en_us&edition=fundamental","pubTime":"2025-03-03 20:00","pubTimestamp":1741003200,"startTime":"0","endTime":"0","summary":"Aura will Participate in the Research Forum at the 40th Annual European Association of Urology Congress Aura will Host a Virtual Urologic Oncology Investor Event Featuring Key Opinion Leaders at 4:30 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/03/3035440/0/en/Aura-Biosciences-Announces-Additional-Data-from-Ongoing-Phase-1-Trial-in-Non-Muscle-Invasive-Bladder-Cancer-to-be-Presented-as-a-Late-Breaking-Abstract-at-the-40th-Annual-European-.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4231","AURA","SITC","BK4080","BK4588","VDC","BK4139","BK4585"],"gpt_icon":0},{"id":"2516389376","title":"Adicet Announces Poster Presentations Highlighting ADI-270 Data at the Society for Immunotherapy of Cancer (SITC) 2025 Spring Scientific Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2516389376","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516389376?lang=en_us&edition=fundamental","pubTime":"2025-03-03 20:00","pubTimestamp":1741003200,"startTime":"0","endTime":"0","summary":"REDWOOD CITY, Calif. & BOSTON, March 03, 2025----Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced the acceptance of two abstracts for poster presentations at the upcoming Society for Immunotherapy of Cancer  2025 Spring Scientific Meeting taking place March 12-14, 2025, in San Diego, C.A.Details of the poster presentation are as follows:. Abstract Title: A Phase 1/2 First in Human Study of ADI-270, an Armored Allogeneic Anti-CD70 Chimeric Antigen Receptor γδ T Cell Therapy, in Relapsed or Refractory (R/R) Clear Cell Renal Cell Carcinoma Poster/Abstract Number: 136Presenting Author: Gregory Vosganian, M.D.Date/Time: Thursday, March 13, 2025, from 5:00 p.m. – 6:30 p.m. PT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adicet-announces-poster-presentations-highlighting-120000270.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4512","LU1670711123.USD","LU0724618433.USD","IE00BZ199S13.USD","LU0957808578.USD","LU1992135472.HKD","LU0719512351.SGD","LU1244550494.USD","LU1992135399.USD","ACET","LU0109392836.USD","LU1642822529.SGD","BK4605","LU1978683503.SGD","LU2237443549.SGD","BK4588","LU0082616367.USD","LU2237443622.USD","LU2272731600.USD","SITC","IE0009356076.USD","LU2458330243.SGD","LU0124384867.USD","LU1670710661.SGD","LU1803068979.SGD","BK4080","BK4139","LU0314104364.USD","LU2237443382.USD","LU1861219969.SGD","LU2298322129.HKD","LU1244550221.USD","LU0444971666.USD","LU2237443978.SGD","BK4141","IE00B5949003.HKD","LU2360107325.USD","ADI","BK4585","LU1074936037.SGD","LU2272731782.SGD","BK4231","LU2237438978.USD","LU1244550577.SGD","LU1670710588.SGD","LU1861214812.USD","BK4515","LU1670711040.USD","LU1815336760.USD"],"gpt_icon":0},{"id":"2516308302","title":"SITE Centers Stock Declines on Q4 OFFO & Revenue Estimate Miss","url":"https://stock-news.laohu8.com/highlight/detail?id=2516308302","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516308302?lang=en_us&edition=fundamental","pubTime":"2025-03-01 00:46","pubTimestamp":1740761160,"startTime":"0","endTime":"0","summary":"Shares of SITE Centers Corp. SITC plunged 5.03% in the Feb. 27 regular trading session on the NYSE after it reported fourth-quarter 2024 operating funds from operations  per share of 16 cents, which missed the Zacks Consensus Estimate of 23 cents.See the Zacks Earnings Calendar to stay ahead of market-making news.SITE Centers generated revenues of $32.9 million, which missed the Zacks Consensus Estimate of $42.7 million.Per David R. Lukes, president and CEO of SITC, “The company’s commenced rate increased through new tenant store openings in an environment of strong leasing demand, and we intend to capitalize where we view strong private market interest in purchasing high-quality assets by marketing a subset of shopping centers for sale. Going forward, SITE Centers intends to maximize value through continued leasing, asset management and potential additional asset sales.”For 2024, SITE Centers reported OFFO per share of $3.17, a decrease of 33% from the prior year’s number. Further, th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/centers-stock-declines-q4-offo-164600553.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SITC","SITE"],"gpt_icon":0},{"id":"2514322613","title":"SITE Centers Is Maintained at Overweight by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2514322613","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514322613?lang=en_us&edition=fundamental","pubTime":"2025-02-28 21:43","pubTimestamp":1740750180,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SITC/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 28, 2025 08:43 ET (13:43 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SITE","SITC"],"gpt_icon":0},{"id":"2514899163","title":"Site Centers Corp reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2514899163","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514899163?lang=en_us&edition=fundamental","pubTime":"2025-02-27 23:14","pubTimestamp":1740669257,"startTime":"0","endTime":"0","summary":"Site Centers Corp reports results for the quarter ended December 31 - Earnings SummarySite Centers Corp SITC.N reported a quarterly adjusted loss of 25 cents per share for the quarter ended December 3","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nL5N3PI23I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SITC"],"gpt_icon":0},{"id":"1187191509","title":"Stock Track | SITE Centers Corp. Plummets 6.84% in Pre-Market on Disappointing Q4 Results and Weak Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=1187191509","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187191509?lang=en_us&edition=fundamental","pubTime":"2025-02-27 22:48","pubTimestamp":1740667681,"startTime":"0","endTime":"0","summary":"SITE Centers Corp. , an owner of open-air shopping centers, saw its stock plummet 6.84% in pre-market trading on Thursday, following the company's disappointing fourth-quarter 2024 financial results and outlook.For the fourth quarter, SITE Centers reported operating funds from operations  of $0.16 per diluted share, significantly missing analysts' expectations of $0.22 per share. The company's quarterly revenues of $32.87 million also fell short of the consensus estimate of $66.78 million.The we","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["SITC"],"gpt_icon":0},{"id":"2514867382","title":"Here's What Key Metrics Tell Us About SITE Centers Corp. (SITC) Q4 Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2514867382","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514867382?lang=en_us&edition=fundamental","pubTime":"2025-02-27 22:30","pubTimestamp":1740666626,"startTime":"0","endTime":"0","summary":"For the quarter ended December 2024, SITE CENTERS CORP.  reported revenue of $32.87 million, down 73.3% over the same period last year. EPS came in at $0.16, compared to $3.68 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $42.65 million, representing a surprise of -22.94%. The company delivered an EPS surprise of -30.43%, with the consensus EPS estimate being $0.23.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.Revenues- Rental income- Percentage and overage rent: $0.63 million versus the two-analyst average estimate of $0.97 million.Revenues- Other property revenues: $0.28 million versus the two-analyst average estimate of $0.53 million.Revenues- Rental income- Ancillary and other rental income: $0.52 million vers","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/heres-key-metrics-tell-us-143026182.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SITC","SITE"],"gpt_icon":0},{"id":"2514385261","title":"Xenetic Biosciences, Inc. Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer (SITC) Spring Scientific 2025 Cell Therapy Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2514385261","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514385261?lang=en_us&edition=fundamental","pubTime":"2025-02-27 22:15","pubTimestamp":1740665700,"startTime":"0","endTime":"0","summary":"FRAMINGHAM, MA / ACCESS Newswire / February 27, 2025 / Xenetic Biosciences, Inc.  , a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers, today announced that its abstract has been accepted for poster presentation at the Society for Immunotherapy of Cancer  Spring Scientific 2025 Cell Therapy Meeting being held March 12 - 14, 2025 in San Diego, CA and virtually.For more information, please visit the conference website here.Xenetic Biosciences, Inc. is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The Company's DNase platform is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps , which are involved in the progression of many human cancers. Xenetic is currently focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreati","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/xenetic-biosciences-inc-announces-abstract-141500377.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["XBIO","BK4080","SITC","BK4231","BK4139","XBIOW"],"gpt_icon":0},{"id":"1113156166","title":"Stock Track | SITE Centers Corp. Plunges 6.46% in Pre-Market on Disappointing Q4 Results and Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=1113156166","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113156166?lang=en_us&edition=fundamental","pubTime":"2025-02-27 21:13","pubTimestamp":1740662011,"startTime":"0","endTime":"0","summary":"SITE Centers Corp. , an owner of open-air shopping centers, plunged 6.46% in pre-market trading on Thursday, following the company's disappointing fourth-quarter 2024 results and outlook.For the fourth quarter, SITE Centers reported operating funds from operations  of $0.16 per diluted share, missing analysts' expectations of $0.22 per share. The company also posted quarterly revenues of $32.87 million, significantly lower than the consensus estimate of $66.78 million.The company attributed the ","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Stock Track | SITE Centers Corp. Plunges 6.46% in Pre-Market on Disappointing Q4 Results and Outlook","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["SITC"],"gpt_icon":0},{"id":"2514596802","title":"IMUNON Reports 2024 Financial Results and Provides Business Update Highlighting Significant Progress Towards the Initiation of a Pivotal Phase 3 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2514596802","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514596802?lang=en_us&edition=fundamental","pubTime":"2025-02-27 21:05","pubTimestamp":1740661500,"startTime":"0","endTime":"0","summary":"IMNN-001 remains the first immunotherapy to achieve a meaningful overall survival benefit in advanced ovarian cancer Patient enrollment in Phase 3 pivotal trial of IMNN-001 scheduled to begin in Q1 20","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/27/3033835/0/en/IMUNON-Reports-2024-Financial-Results-and-Provides-Business-Update-Highlighting-Significant-Progress-Towards-the-Initiation-of-a-Pivotal-Phase-3-Study.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0170899867.USD","LU0882574139.USD","IE00B1BXHZ80.USD","IE00BKVL7J92.USD","BK4097","BK4080","LU0267386448.USD","LU2065732104.USD","OS","IE00BZ1G4Q59.USD","PFS","LU1363072403.SGD","BK4195","CMC","BK4211","BK4139","LU0149725797.USD","BK4006","BK4203","PRGS","BK4225","IMNN","HR","BK4231","LU0971096721.USD","SITC","IE00BHPRN162.USD"],"gpt_icon":0},{"id":"2514388880","title":"SITE CENTERS CORP. (SITC) Misses Q4 FFO and Revenue Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2514388880","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514388880?lang=en_us&edition=fundamental","pubTime":"2025-02-27 20:40","pubTimestamp":1740660004,"startTime":"0","endTime":"0","summary":"SITE CENTERS CORP.  came out with quarterly funds from operations  of $0.16 per share, missing the Zacks Consensus Estimate of $0.23 per share. This compares to FFO of $1.04 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an FFO surprise of -30.43%. A quarter ago, it was expected that this company would post FFO of $0.87 per share when it actually produced FFO of $0.81, delivering a surprise of -6.90%.Over the last four quarters, the company has surpassed consensus FFO estimates two times.SITE Centers Corp. , which belongs to the Zacks REIT and Equity Trust - Retail industry, posted revenues of $32.87 million for the quarter ended December 2024, missing the Zacks Consensus Estimate by 22.94%. This compares to year-ago revenues of $123.16 million. The company has topped consensus revenue estimates just once over the last four quarters.Investors should be mindful of the fact that the outlook for the industry can have a material im","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/centers-corp-sitc-misses-q4-124004719.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CORP","SITE","SITC","BFS"],"gpt_icon":0},{"id":"2514085488","title":"SITE Centers Q4 FFO $0.16 Misses $0.22 Estimate, Sales $32.87M Miss $66.78M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2514085488","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514085488?lang=en_us&edition=fundamental","pubTime":"2025-02-27 19:31","pubTimestamp":1740655908,"startTime":"0","endTime":"0","summary":"SITE Centers (NYSE:SITC) reported quarterly earnings of $0.16 per share which missed the analyst consensus estimate of $0.22 by 27.27 percent. This is a 84.47 percent decrease over earnings of $1.03 per share from the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/02/44001682/site-centers-q4-ffo-0-16-misses-0-22-estimate-sales-32-87m-miss-66-78m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SITC","SITE"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":65,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SITC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-07","symbol":"SITC","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746590400000,"reportTimeType":"post","actualEps":0.16},{"market":"US","date":"2025-02-27","symbol":"SITC","fiscalQuarterEnding":"2024/12","expectedEps":0.23,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"pre","actualEps":0.16},{"market":"US","date":"2024-10-30","symbol":"SITC","fiscalQuarterEnding":"2024/09","expectedEps":0.87,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730260800000,"reportTimeType":"pre","actualEps":0.81},{"market":"US","date":"2024-08-19","symbol":"SITC","defaultRemindTime":1724074200000,"type":"split","dateTimestamp":1724040000000,"forFactor":4,"toFactor":1,"ratio":4},{"date":"2024-07-30","symbol":"SITC","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1722326400000,"name":null,"time":"Pre-Market","dateTimestamp":1722312000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SITC\",market:\"US\",,,undefined,":[{"executeDate":"2015-09-18","recordDate":"2015-09-22","paymentDate":"2015-10-09","value":0.1725,"currency":"USD"},{"executeDate":"2015-12-11","recordDate":"2015-12-15","paymentDate":"2016-01-05","value":0.1725,"currency":"USD"},{"executeDate":"2016-03-08","recordDate":"2016-03-10","paymentDate":"2016-04-05","value":0.19,"currency":"USD"},{"executeDate":"2016-06-07","recordDate":"2016-06-09","paymentDate":"2016-07-06","value":0.19,"currency":"USD"},{"executeDate":"2016-09-21","recordDate":"2016-09-23","paymentDate":"2016-10-11","value":0.19,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SITC\",market:\"US\",delay:true,,,undefined,":{"strongBuy":0,"buy":0.2,"hold":0.8,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.8,"analysts":5,"updateTime":1728446400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SITC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:true,algorithm:1,,,undefined,":{"brief":{"id":"SITC","date":"2025-06-13","current":1.115647,"percent":0.056876,"low":0.676862,"twenty":10.945567,"median":19.867235,"eighty":48.464304,"high":191.31255,"avg":33.515659,"sd":41.843298,"marketCap":623045388},"quantilePoints":[{"date":"2020-06-19","current":14.743984,"twenty":-26.648569,"median":9.86282,"eighty":24.16559,"marketCap":1463222456},{"date":"2020-06-26","current":14.49045,"twenty":-26.407324,"median":9.953304,"eighty":24.16559,"marketCap":1438061223},{"date":"2020-07-02","current":15.504586,"twenty":-26.133311,"median":10.028708,"eighty":24.16559,"marketCap":1538706154},{"date":"2020-07-10","current":14.665973,"twenty":-25.913845,"median":10.102322,"eighty":24.16559,"marketCap":1455480538},{"date":"2020-07-17","current":14.061392,"twenty":-25.711202,"median":10.179516,"eighty":24.16559,"marketCap":1395480676},{"date":"2020-07-24","current":13.495816,"twenty":-24.931447,"median":10.239839,"eighty":24.16559,"marketCap":1339351772},{"date":"2020-07-31","current":18.340911,"twenty":-22.406996,"median":10.307702,"eighty":24.16559,"marketCap":1418706128},{"date":"2020-08-07","current":19.516931,"twenty":-21.330192,"median":10.413749,"eighty":24.055579,"marketCap":1509673643},{"date":"2020-08-14","current":20.167495,"twenty":-21.330192,"median":10.413749,"eighty":23.592655,"marketCap":1559996098},{"date":"2020-08-21","current":18.491041,"twenty":-21.330192,"median":10.413749,"eighty":23.022214,"marketCap":1430319003},{"date":"2020-08-28","current":19.491909,"twenty":-21.330192,"median":10.413749,"eighty":22.482127,"marketCap":1507738164},{"date":"2020-09-04","current":20.768016,"twenty":-21.330192,"median":10.413749,"eighty":21.985969,"marketCap":1606447594},{"date":"2020-09-11","current":18.866367,"twenty":-21.330192,"median":10.413749,"eighty":21.745755,"marketCap":1459351188},{"date":"2020-09-18","current":19.341779,"twenty":-21.330192,"median":10.413749,"eighty":21.65885,"marketCap":1496125290},{"date":"2020-09-25","current":17.164891,"twenty":-21.330192,"median":10.413749,"eighty":21.442484,"marketCap":1327738614},{"date":"2020-10-02","current":19.06654,"twenty":-21.330192,"median":10.413749,"eighty":21.277267,"marketCap":1474835020},{"date":"2020-10-09","current":19.266714,"twenty":-21.330192,"median":10.413749,"eighty":21.073882,"marketCap":1490318853},{"date":"2020-10-16","current":18.265846,"twenty":-21.330192,"median":10.413749,"eighty":20.884694,"marketCap":1412899691},{"date":"2020-10-23","current":19.21667,"twenty":-21.330192,"median":10.413749,"eighty":20.760363,"marketCap":1486447895},{"date":"2020-10-30","current":21.583486,"twenty":-21.330192,"median":10.413749,"eighty":20.72975,"marketCap":1316786918},{"date":"2020-11-06","current":21.805343,"twenty":-21.330192,"median":10.413749,"eighty":20.72975,"marketCap":1330322173},{"date":"2020-11-13","current":29.158308,"twenty":-21.330192,"median":10.413749,"eighty":20.72975,"marketCap":1778919185},{"date":"2020-11-20","current":32.866484,"twenty":-21.330192,"median":10.413749,"eighty":20.72975,"marketCap":2005151298},{"date":"2020-11-27","current":33.880686,"twenty":-21.330192,"median":10.413749,"eighty":20.72975,"marketCap":2067026748},{"date":"2020-12-04","current":33.595441,"twenty":-21.330192,"median":10.413749,"eighty":20.72975,"marketCap":2049624278},{"date":"2020-12-11","current":32.612933,"twenty":-21.330192,"median":10.413749,"eighty":20.72975,"marketCap":1989682436},{"date":"2020-12-18","current":32.264301,"twenty":-21.330192,"median":10.413749,"eighty":20.72975,"marketCap":1968412750},{"date":"2020-12-24","current":32.42277,"twenty":-21.330192,"median":10.413749,"eighty":20.72975,"marketCap":1978080789},{"date":"2020-12-31","current":32.074138,"twenty":-21.330192,"median":10.413749,"eighty":20.72975,"marketCap":1956811103},{"date":"2021-01-08","current":32.612933,"twenty":-21.330192,"median":10.413749,"eighty":20.72975,"marketCap":1989682436},{"date":"2021-01-15","current":36.257722,"twenty":-21.330192,"median":10.413749,"eighty":20.72975,"marketCap":2212047334},{"date":"2021-01-22","current":36.035865,"twenty":-21.330192,"median":10.413749,"eighty":20.72975,"marketCap":2198512079},{"date":"2021-01-29","current":35.148438,"twenty":-21.330192,"median":10.413749,"eighty":20.72975,"marketCap":2144371061},{"date":"2021-02-05","current":36.733129,"twenty":-21.330192,"median":10.413749,"eighty":20.72975,"marketCap":2241051451},{"date":"2021-02-12","current":39.046777,"twenty":-21.330192,"median":10.413749,"eighty":20.72975,"marketCap":2382204821},{"date":"2021-02-19","current":69.717994,"twenty":-21.330192,"median":10.413749,"eighty":20.72975,"marketCap":2490396480},{"date":"2021-02-26","current":72.267886,"twenty":-21.330192,"median":10.413749,"eighty":20.72975,"marketCap":2581481162},{"date":"2021-03-05","current":71.809955,"twenty":-21.346772,"median":10.405985,"eighty":20.72975,"marketCap":2565123415},{"date":"2021-03-12","current":77.175378,"twenty":-21.346772,"median":10.405985,"eighty":20.72975,"marketCap":2756781692},{"date":"2021-03-19","current":72.731291,"twenty":-21.346772,"median":10.405985,"eighty":20.72975,"marketCap":2598034432},{"date":"2021-03-26","current":72.948075,"twenty":-21.330192,"median":10.413749,"eighty":20.72975,"marketCap":2605778201},{"date":"2021-04-01","current":81.578891,"twenty":-21.330192,"median":10.413749,"eighty":20.72975,"marketCap":2914079580},{"date":"2021-04-09","current":81.815352,"twenty":-21.346772,"median":10.405985,"eighty":20.72975,"marketCap":2922526188},{"date":"2021-04-16","current":83.175,"twenty":-21.346772,"median":10.405985,"eighty":20.72975,"marketCap":2971094181},{"date":"2021-04-23","current":181.722513,"twenty":-21.346772,"median":10.405985,"eighty":20.72975,"marketCap":3161244840},{"date":"2021-04-30","current":179.052037,"twenty":-21.330192,"median":10.413749,"eighty":20.72975,"marketCap":3114789242},{"date":"2021-05-07","current":179.416211,"twenty":-21.031751,"median":10.45851,"eighty":20.808051,"marketCap":3121124406},{"date":"2021-05-14","current":179.29482,"twenty":-20.26078,"median":10.628891,"eighty":20.953183,"marketCap":3119012685},{"date":"2021-05-21","current":174.439171,"twenty":-19.86286,"median":10.760125,"eighty":21.17332,"marketCap":3034543824},{"date":"2021-05-28","current":181.722644,"twenty":-19.59758,"median":10.843553,"eighty":21.350211,"marketCap":3161247115},{"date":"2021-06-04","current":182.936556,"twenty":-19.353025,"median":10.873231,"eighty":21.458393,"marketCap":3182364330},{"date":"2021-06-11","current":190.584202,"twenty":-19.149919,"median":10.903393,"eighty":21.641205,"marketCap":3315402786},{"date":"2021-06-18","current":176.409606,"twenty":-18.959249,"median":10.936392,"eighty":21.742594,"marketCap":3068821509},{"date":"2021-06-25","current":181.236134,"twenty":-18.814174,"median":10.978796,"eighty":21.900316,"marketCap":3152783794},{"date":"2021-07-02","current":180.029502,"twenty":-18.727129,"median":11.057988,"eighty":22.173572,"marketCap":3131793223},{"date":"2021-07-09","current":182.684093,"twenty":-18.586199,"median":11.106983,"eighty":22.491948,"marketCap":3177972479},{"date":"2021-07-16","current":180.874145,"twenty":-18.233873,"median":11.137144,"eighty":22.927256,"marketCap":3146486622},{"date":"2021-07-23","current":182.925419,"twenty":-17.939578,"median":11.182387,"eighty":23.358886,"marketCap":3182170593},{"date":"2021-07-30","current":76.747214,"twenty":-16.640313,"median":11.272517,"eighty":23.834401,"marketCap":3367514261},{"date":"2021-08-06","current":77.618242,"twenty":-13.565429,"median":11.299781,"eighty":24.16559,"marketCap":3405733212},{"date":"2021-08-13","current":75.972967,"twenty":-13.112133,"median":11.361721,"eighty":24.324535,"marketCap":3333541859},{"date":"2021-08-20","current":75.15033,"twenty":-12.911344,"median":11.454504,"eighty":24.606186,"marketCap":3297446183},{"date":"2021-08-27","current":78.392489,"twenty":-12.075456,"median":11.512149,"eighty":24.862689,"marketCap":3439705613},{"date":"2021-09-03","current":78.198927,"twenty":-11.874284,"median":11.597108,"eighty":25.159211,"marketCap":3431212513},{"date":"2021-09-10","current":73.940569,"twenty":-11.75983,"median":11.640455,"eighty":25.890766,"marketCap":3244364306},{"date":"2021-09-17","current":76.166529,"twenty":-11.543848,"median":11.70682,"eighty":26.965347,"marketCap":3342034960},{"date":"2021-09-24","current":75.440673,"twenty":-11.486784,"median":11.716711,"eighty":27.504909,"marketCap":3310185834},{"date":"2021-10-01","current":78.102146,"twenty":-11.402384,"median":11.75737,"eighty":30.033057,"marketCap":3426965962},{"date":"2021-10-08","current":79.74742,"twenty":-11.350665,"median":11.786459,"eighty":31.459278,"marketCap":3499157315},{"date":"2021-10-15","current":80.957181,"twenty":-11.268524,"median":11.806148,"eighty":32.112171,"marketCap":3552239192},{"date":"2021-10-22","current":79.457078,"twenty":-11.223146,"median":11.817362,"eighty":32.264301,"marketCap":3486417664},{"date":"2021-10-29","current":52.174647,"twenty":-11.138413,"median":11.840788,"eighty":32.536868,"marketCap":3373351803},{"date":"2021-11-05","current":56.705862,"twenty":-11.085883,"median":11.869677,"eighty":32.866484,"marketCap":3666317535},{"date":"2021-11-12","current":54.735769,"twenty":-11.037694,"median":11.879948,"eighty":33.08834,"marketCap":3538941130},{"date":"2021-11-19","current":54.47309,"twenty":-10.975399,"median":11.890583,"eighty":33.690522,"marketCap":3521957609},{"date":"2021-11-26","current":51.911968,"twenty":-10.953528,"median":11.911488,"eighty":34.888549,"marketCap":3356368282},{"date":"2021-12-03","current":50.532902,"twenty":-10.89362,"median":11.945735,"eighty":35.560457,"marketCap":3267204798},{"date":"2021-12-10","current":50.138884,"twenty":-10.817339,"median":11.974047,"eighty":36.333787,"marketCap":3241729517},{"date":"2021-12-17","current":49.219507,"twenty":-10.600022,"median":12.007676,"eighty":37.012034,"marketCap":3182287194},{"date":"2021-12-23","current":50.007544,"twenty":-10.56133,"median":12.028522,"eighty":38.153012,"marketCap":3233237757},{"date":"2021-12-31","current":51.977638,"twenty":-10.39631,"median":12.06347,"eighty":44.31339,"marketCap":3360614162},{"date":"2022-01-07","current":52.634336,"twenty":-9.93569,"median":12.078465,"eighty":48.589077,"marketCap":3403072964},{"date":"2022-01-14","current":52.568666,"twenty":-9.638521,"median":12.105553,"eighty":49.71203,"marketCap":3398827084},{"date":"2022-01-21","current":47.938946,"twenty":-9.582274,"median":12.145744,"eighty":50.033812,"marketCap":3099492531},{"date":"2022-01-28","current":49.121002,"twenty":-9.497901,"median":12.173878,"eighty":50.020678,"marketCap":3175918374},{"date":"2022-02-04","current":48.10312,"twenty":-9.334514,"median":12.273341,"eighty":50.020678,"marketCap":3110107231},{"date":"2022-02-11","current":25.801244,"twenty":-9.280832,"median":12.332854,"eighty":50.020678,"marketCap":3223478403},{"date":"2022-02-18","current":26.190377,"twenty":-9.20764,"median":13.101808,"eighty":50.020678,"marketCap":3272094798},{"date":"2022-02-25","current":27.08718,"twenty":-9.116217,"median":13.301412,"eighty":50.020678,"marketCap":3384136804},{"date":"2022-03-04","current":27.070261,"twenty":-9.081397,"median":13.410358,"eighty":50.020678,"marketCap":3382023040},{"date":"2022-03-11","current":27.188693,"twenty":-8.932741,"median":13.565493,"eighty":50.020678,"marketCap":3396819390},{"date":"2022-03-18","current":27.662423,"twenty":-8.804174,"median":13.68492,"eighty":50.020678,"marketCap":3456004794},{"date":"2022-03-25","current":27.39172,"twenty":-8.566101,"median":13.926879,"eighty":50.020678,"marketCap":3422184563},{"date":"2022-04-01","current":28.491854,"twenty":-8.494418,"median":14.014538,"eighty":50.020678,"marketCap":3559629780},{"date":"2022-04-08","current":27.224423,"twenty":-8.455252,"median":14.140785,"eighty":50.020678,"marketCap":3401283260},{"date":"2022-04-14","current":27.731395,"twenty":-8.413437,"median":14.285152,"eighty":50.020678,"marketCap":3464621868},{"date":"2022-04-22","current":27.900386,"twenty":-8.335201,"median":14.519704,"eighty":50.020678,"marketCap":3485734737},{"date":"2022-04-29","current":27.689747,"twenty":-8.214908,"median":14.675724,"eighty":50.020678,"marketCap":3402073026},{"date":"2022-05-06","current":26.74934,"twenty":-8.105599,"median":14.753735,"eighty":50.020678,"marketCap":3286530923},{"date":"2022-05-13","current":26.226892,"twenty":-8.073018,"median":14.835984,"eighty":50.020678,"marketCap":3222340866},{"date":"2022-05-20","current":24.119685,"twenty":-8.034568,"median":14.935298,"eighty":50.020678,"marketCap":2963440969},{"date":"2022-05-27","current":27.863896,"twenty":-7.999038,"median":15.080449,"eighty":50.020678,"marketCap":3423469712},{"date":"2022-06-03","current":26.74934,"twenty":-7.950425,"median":15.095031,"eighty":50.020678,"marketCap":3286530923},{"date":"2022-06-10","current":23.823631,"twenty":-7.90537,"median":15.234506,"eighty":50.020678,"marketCap":2927066603},{"date":"2022-06-17","current":22.674245,"twenty":-7.776056,"median":15.309635,"eighty":50.020678,"marketCap":2785848478},{"date":"2022-06-24","current":23.858461,"twenty":-7.729466,"median":15.462379,"eighty":50.033812,"marketCap":2931345940},{"date":"2022-07-01","current":23.753971,"twenty":-7.570482,"median":15.660607,"eighty":50.033812,"marketCap":2918507929},{"date":"2022-07-08","current":23.231523,"twenty":-7.513609,"median":15.75812,"eighty":50.033812,"marketCap":2854317872},{"date":"2022-07-15","current":23.318598,"twenty":-7.390816,"median":17.01476,"eighty":50.033812,"marketCap":2865016215},{"date":"2022-07-22","current":24.224175,"twenty":-7.304216,"median":17.915542,"eighty":50.033812,"marketCap":2976278980},{"date":"2022-07-29","current":19.389716,"twenty":-7.195641,"median":18.065672,"eighty":50.033812,"marketCap":3129209334},{"date":"2022-08-05","current":18.580152,"twenty":-7.014684,"median":18.26585,"eighty":50.033812,"marketCap":2998557884},{"date":"2022-08-12","current":19.933849,"twenty":-7.014684,"median":18.491041,"eighty":50.033812,"marketCap":3217024244},{"date":"2022-08-19","current":19.190643,"twenty":-7.014684,"median":18.641171,"eighty":50.033812,"marketCap":3097081928},{"date":"2022-08-26","current":17.903304,"twenty":-7.014684,"median":18.641171,"eighty":50.033812,"marketCap":2889324703},{"date":"2022-09-02","current":17.000839,"twenty":-7.014684,"median":18.641171,"eighty":50.033812,"marketCap":2743680463},{"date":"2022-09-09","current":17.823675,"twenty":-7.014684,"median":18.641171,"eighty":50.033812,"marketCap":2876473741},{"date":"2022-09-16","current":17.027382,"twenty":-7.014684,"median":18.641171,"eighty":50.033812,"marketCap":2747964117},{"date":"2022-09-23","current":14.996837,"twenty":-7.014684,"median":18.641171,"eighty":50.033812,"marketCap":2420264577},{"date":"2022-09-30","current":14.213817,"twenty":-7.014684,"median":18.641171,"eighty":50.033812,"marketCap":2293896781},{"date":"2022-10-07","current":14.187273,"twenty":-7.014684,"median":18.641171,"eighty":50.033812,"marketCap":2289613127},{"date":"2022-10-14","current":14.492519,"twenty":-7.014684,"median":18.641171,"eighty":50.033812,"marketCap":2338875149},{"date":"2022-10-21","current":15.341897,"twenty":-7.014684,"median":18.641171,"eighty":50.033812,"marketCap":2475952081},{"date":"2022-10-28","current":13.19515,"twenty":-7.014684,"median":18.641171,"eighty":50.033812,"marketCap":2632643607},{"date":"2022-11-04","current":13.216467,"twenty":-7.014684,"median":18.61615,"eighty":50.033812,"marketCap":2636896666},{"date":"2022-11-11","current":13.983875,"twenty":-7.014684,"median":18.491041,"eighty":50.033812,"marketCap":2790006795},{"date":"2022-11-18","current":14.090459,"twenty":-7.014684,"median":18.354536,"eighty":50.033812,"marketCap":2811272091},{"date":"2022-11-25","current":14.229019,"twenty":-7.014684,"median":18.265846,"eighty":50.033812,"marketCap":2838916975},{"date":"2022-12-02","current":14.420871,"twenty":-7.014684,"median":18.022748,"eighty":50.033812,"marketCap":2877194508},{"date":"2022-12-09","current":14.143752,"twenty":-7.014684,"median":17.915542,"eighty":50.033812,"marketCap":2821904739},{"date":"2022-12-16","current":13.962558,"twenty":-7.014684,"median":17.61133,"eighty":50.033812,"marketCap":2785753736},{"date":"2022-12-23","current":14.516797,"twenty":-7.014684,"median":17.199912,"eighty":50.033812,"marketCap":2896333274},{"date":"2022-12-30","current":14.559431,"twenty":-7.014684,"median":17.053926,"eighty":50.033812,"marketCap":2904839392},{"date":"2023-01-06","current":13.930583,"twenty":-7.014684,"median":16.934482,"eighty":49.311445,"marketCap":2779374147},{"date":"2023-01-13","current":14.090459,"twenty":-7.014684,"median":16.483249,"eighty":48.726983,"marketCap":2811272091},{"date":"2023-01-20","current":13.728072,"twenty":-7.014684,"median":15.75812,"eighty":48.536541,"marketCap":2738970086},{"date":"2023-01-27","current":14.314287,"twenty":-7.014684,"median":15.639909,"eighty":48.346098,"marketCap":2855929212},{"date":"2023-02-03","current":14.697991,"twenty":-7.014684,"median":15.341897,"eighty":47.722236,"marketCap":2932484277},{"date":"2023-02-10","current":17.431293,"twenty":-7.014684,"median":15.251052,"eighty":38.894647,"marketCap":2940990395},{"date":"2023-02-17","current":17.343066,"twenty":8.24554,"median":15.341897,"eighty":38.102301,"marketCap":2926104688},{"date":"2023-02-24","current":16.869169,"twenty":9.088908,"median":15.504586,"eighty":38.102301,"marketCap":2846149307},{"date":"2023-03-03","current":16.582193,"twenty":9.410881,"median":15.699613,"eighty":38.102301,"marketCap":2797731086},{"date":"2023-03-10","current":15.184747,"twenty":9.562713,"median":15.855634,"eighty":38.102301,"marketCap":2561955404},{"date":"2023-03-17","current":14.585842,"twenty":9.657722,"median":15.855634,"eighty":38.102301,"marketCap":2460908683},{"date":"2023-03-24","current":14.336298,"twenty":9.754238,"median":15.855634,"eighty":38.102301,"marketCap":2418805882},{"date":"2023-03-31","current":15.321997,"twenty":9.852263,"median":15.82638,"eighty":38.051591,"marketCap":2585111944},{"date":"2023-04-06","current":14.872818,"twenty":9.90203,"median":15.82638,"eighty":38.051591,"marketCap":2509326903},{"date":"2023-04-14","current":14.735568,"twenty":10.022676,"median":15.855634,"eighty":38.102301,"marketCap":2486170363},{"date":"2023-04-21","current":14.880945,"twenty":10.100022,"median":15.855634,"eighty":38.102301,"marketCap":2510698158},{"date":"2023-04-28","current":14.923106,"twenty":10.170468,"median":15.855634,"eighty":38.102301,"marketCap":2537912886},{"date":"2023-05-05","current":14.67685,"twenty":10.236823,"median":15.855634,"eighty":38.102301,"marketCap":2496033135},{"date":"2023-05-12","current":14.332092,"twenty":10.260952,"median":16.032017,"eighty":38.343175,"marketCap":2437401484},{"date":"2023-05-22","current":14.492158,"twenty":10.41424,"median":16.464097,"eighty":38.717161,"marketCap":2464623322},{"date":"2023-06-16","current":16.252887,"twenty":10.785762,"median":16.750679,"eighty":44.31339,"marketCap":2764063539},{"date":"2023-07-28","current":25.197394,"twenty":11.00463,"median":17.27564,"eighty":48.162223,"marketCap":2898431050},{"date":"2023-08-04","current":25.397618,"twenty":11.073225,"median":17.435046,"eighty":48.162223,"marketCap":2921462610},{"date":"2023-08-11","current":25.361232,"twenty":11.128106,"median":17.546519,"eighty":48.162223,"marketCap":2917277134},{"date":"2023-08-18","current":23.614691,"twenty":11.160198,"median":17.909423,"eighty":48.162223,"marketCap":2716374261},{"date":"2023-08-25","current":23.396373,"twenty":11.239305,"median":18.019188,"eighty":48.162223,"marketCap":2691261402},{"date":"2023-09-01","current":24.287837,"twenty":11.28108,"median":18.215803,"eighty":48.162223,"marketCap":2793805577},{"date":"2023-09-08","current":24.688086,"twenty":11.315392,"median":18.347724,"eighty":48.162223,"marketCap":2839845818},{"date":"2023-09-15","current":25.070142,"twenty":11.396477,"median":18.491041,"eighty":48.162223,"marketCap":2883793322},{"date":"2023-09-22","current":23.269021,"twenty":11.501531,"median":18.611422,"eighty":48.162223,"marketCap":2676612234},{"date":"2023-09-29","current":22.632261,"twenty":11.565241,"median":18.741258,"eighty":48.162223,"marketCap":2603366395},{"date":"2023-10-06","current":21.431514,"twenty":11.628551,"median":18.862611,"eighty":48.162223,"marketCap":2465245670},{"date":"2023-10-13","current":22.068274,"twenty":11.70682,"median":18.941436,"eighty":48.181924,"marketCap":2538491509},{"date":"2023-10-20","current":21.249583,"twenty":11.715669,"median":19.06654,"eighty":48.181924,"marketCap":2444318287},{"date":"2023-10-27","current":20.721982,"twenty":11.751549,"median":19.203657,"eighty":48.201625,"marketCap":2383628878},{"date":"2023-11-03","current":26.691875,"twenty":11.782919,"median":19.301672,"eighty":48.201625,"marketCap":2601817183},{"date":"2023-11-10","current":27.379035,"twenty":11.804156,"median":19.390769,"eighty":48.201625,"marketCap":2668798800},{"date":"2023-11-17","current":28.15209,"twenty":11.816178,"median":19.513046,"eighty":48.201625,"marketCap":2744153119},{"date":"2023-11-24","current":28.173564,"twenty":11.823271,"median":19.79217,"eighty":48.201625,"marketCap":2746246295},{"date":"2023-12-01","current":28.32388,"twenty":11.861543,"median":19.975607,"eighty":48.201625,"marketCap":2760898524},{"date":"2023-12-08","current":28.903671,"twenty":11.874946,"median":20.117452,"eighty":48.201625,"marketCap":2817414263},{"date":"2023-12-15","current":31.029573,"twenty":11.888522,"median":20.221885,"eighty":48.201625,"marketCap":3024638640},{"date":"2023-12-22","current":29.590831,"twenty":11.91034,"median":20.427474,"eighty":48.201625,"marketCap":2884395880},{"date":"2023-12-29","current":29.891464,"twenty":11.93663,"median":20.530884,"eighty":48.227893,"marketCap":2913700337},{"date":"2024-01-05","current":28.753355,"twenty":11.951044,"median":20.666113,"eighty":48.254161,"marketCap":2802762034},{"date":"2024-01-12","current":29.633779,"twenty":11.976942,"median":20.72975,"eighty":48.254161,"marketCap":2888582231},{"date":"2024-01-19","current":29.053988,"twenty":12.012067,"median":20.854609,"eighty":48.280428,"marketCap":2832066492},{"date":"2024-01-26","current":29.741148,"twenty":12.050866,"median":20.968389,"eighty":48.254161,"marketCap":2899048109},{"date":"2024-02-02","current":28.968093,"twenty":12.078465,"median":21.176825,"eighty":48.254161,"marketCap":2823693789},{"date":"2024-02-09","current":29.590831,"twenty":12.105337,"median":21.286574,"eighty":48.254161,"marketCap":2884395880},{"date":"2024-02-16","current":11.273805,"twenty":12.121334,"median":21.376935,"eighty":48.254161,"marketCap":2995483680},{"date":"2024-02-23","current":11.068969,"twenty":12.102013,"median":21.36612,"eighty":48.254161,"marketCap":2941058400},{"date":"2024-03-01","current":10.700192,"twenty":12.076695,"median":21.244812,"eighty":48.227893,"marketCap":2843073179},{"date":"2024-03-08","current":11.117799,"twenty":12.048043,"median":21.244812,"eighty":48.227893,"marketCap":2954032589},{"date":"2024-03-15","current":11.039005,"twenty":12.007676,"median":21.208433,"eighty":48.227893,"marketCap":2933096851},{"date":"2024-03-22","current":11.401457,"twenty":11.975106,"median":21.131335,"eighty":48.227893,"marketCap":3029401245},{"date":"2024-03-28","current":11.409336,"twenty":11.945735,"median":20.971378,"eighty":48.227893,"marketCap":3031494818},{"date":"2024-04-05","current":11.033059,"twenty":11.914716,"median":20.721982,"eighty":48.254161,"marketCap":2931516936},{"date":"2024-04-12","current":10.946309,"twenty":11.890995,"median":20.267582,"eighty":48.254161,"marketCap":2908467125},{"date":"2024-04-19","current":10.686058,"twenty":11.87564,"median":20.117452,"eighty":48.254161,"marketCap":2839317690},{"date":"2024-04-26","current":10.741263,"twenty":11.874946,"median":20.042474,"eighty":48.227893,"marketCap":2853985752},{"date":"2024-05-03","current":12.801669,"twenty":11.874946,"median":20.042474,"eighty":48.227893,"marketCap":2904276250},{"date":"2024-05-10","current":12.912467,"twenty":11.874946,"median":20.042474,"eighty":48.227893,"marketCap":2929412621},{"date":"2024-05-17","current":13.180322,"twenty":11.874946,"median":20.042474,"eighty":48.227893,"marketCap":2990180122},{"date":"2024-05-24","current":13.097195,"twenty":11.886038,"median":20.042474,"eighty":48.227893,"marketCap":2971321243},{"date":"2024-05-31","current":13.115667,"twenty":11.888522,"median":20.042474,"eighty":48.227893,"marketCap":2975512105},{"date":"2024-06-07","current":13.549777,"twenty":11.91541,"median":20.042474,"eighty":48.227893,"marketCap":3073997365},{"date":"2024-06-14","current":13.577487,"twenty":11.9744,"median":20.067408,"eighty":48.254161,"marketCap":3080283658},{"date":"2024-06-21","current":13.355813,"twenty":11.976264,"median":20.09243,"eighty":48.280428,"marketCap":3029993312},{"date":"2024-06-28","current":13.217268,"twenty":12.015039,"median":20.119651,"eighty":48.339531,"marketCap":2998561846},{"date":"2024-07-05","current":13.383523,"twenty":12.067158,"median":20.119651,"eighty":48.339531,"marketCap":3036279605},{"date":"2024-07-12","current":13.90076,"twenty":12.108178,"median":20.119651,"eighty":48.339531,"marketCap":3153623745},{"date":"2024-07-15","current":14.067015,"twenty":12.125501,"median":20.119651,"eighty":48.339531,"marketCap":3191341504},{"date":"2024-08-02","current":7.046799,"twenty":12.504257,"median":20.573716,"eighty":48.45117,"marketCap":3239829432},{"date":"2024-08-09","current":6.955638,"twenty":12.504257,"median":20.573716,"eighty":48.45117,"marketCap":3197917020},{"date":"2024-08-16","current":7.028567,"twenty":12.504257,"median":20.573716,"eighty":48.45117,"marketCap":3231446949},{"date":"2024-08-23","current":6.900941,"twenty":12.504257,"median":20.573716,"eighty":48.45117,"marketCap":3172769527},{"date":"2024-08-30","current":6.862197,"twenty":12.504257,"median":20.573716,"eighty":48.45117,"marketCap":3154956753},{"date":"2024-09-06","current":6.584154,"twenty":12.504257,"median":20.573716,"eighty":48.45117,"marketCap":3027123898},{"date":"2024-09-13","current":6.750524,"twenty":12.504257,"median":20.573716,"eighty":48.45117,"marketCap":3103614049},{"date":"2024-09-20","current":6.780151,"twenty":12.504257,"median":20.573716,"eighty":48.45117,"marketCap":3117235583},{"date":"2024-09-27","current":6.750524,"twenty":12.504257,"median":20.573716,"eighty":48.45117,"marketCap":3103614049},{"date":"2024-10-04","current":1.931488,"twenty":12.504257,"median":20.573716,"eighty":48.45117,"marketCap":888019212},{"date":"2024-10-11","current":1.961116,"twenty":12.504257,"median":20.573716,"eighty":48.45117,"marketCap":901640745},{"date":"2024-10-18","current":1.916675,"twenty":12.504257,"median":20.573716,"eighty":48.45117,"marketCap":881208445},{"date":"2024-10-25","current":1.956558,"twenty":12.199762,"median":20.573716,"eighty":48.45117,"marketCap":899545125},{"date":"2024-10-31","current":0.676862,"twenty":11.943647,"median":20.573716,"eighty":48.45117,"marketCap":860776145},{"date":"2024-11-08","current":1.136209,"twenty":11.975812,"median":20.642908,"eighty":48.464304,"marketCap":834056982},{"date":"2024-11-15","current":1.12479,"twenty":11.975812,"median":20.642908,"eighty":48.464304,"marketCap":825674500},{"date":"2024-11-22","current":1.154211,"twenty":11.975812,"median":20.642908,"eighty":48.464304,"marketCap":847271401},{"date":"2024-11-29","current":1.108499,"twenty":11.975812,"median":20.642908,"eighty":48.464304,"marketCap":813716098},{"date":"2024-12-06","current":1.0985,"twenty":11.975812,"median":20.642908,"eighty":48.464304,"marketCap":806375876},{"date":"2024-12-13","current":1.112785,"twenty":11.975812,"median":20.642908,"eighty":48.464304,"marketCap":816861908},{"date":"2024-12-20","current":1.072073,"twenty":11.975812,"median":20.642908,"eighty":48.464304,"marketCap":786976716},{"date":"2024-12-27","current":1.0935,"twenty":11.975812,"median":20.642908,"eighty":48.464304,"marketCap":802705764},{"date":"2025-01-03","current":1.071359,"twenty":11.975812,"median":20.642908,"eighty":48.464304,"marketCap":786452415},{"date":"2025-01-10","current":1.067788,"twenty":12.08223,"median":20.682445,"eighty":48.464304,"marketCap":783830906},{"date":"2025-01-17","current":1.0935,"twenty":12.08223,"median":20.682445,"eighty":48.464304,"marketCap":802705764},{"date":"2025-01-24","current":1.089215,"twenty":12.08223,"median":20.682445,"eighty":48.464304,"marketCap":799559955},{"date":"2025-01-31","current":1.087786,"twenty":12.08223,"median":20.682445,"eighty":48.464304,"marketCap":798511352},{"date":"2025-02-07","current":1.082072,"twenty":12.08223,"median":20.682445,"eighty":48.464304,"marketCap":794316939},{"date":"2025-02-14","current":1.078501,"twenty":11.967771,"median":20.573716,"eighty":48.464304,"marketCap":791695431},{"date":"2025-02-21","current":1.05136,"twenty":11.815098,"median":20.171841,"eighty":48.464304,"marketCap":771771969},{"date":"2025-02-28","current":1.360481,"twenty":11.549812,"median":20.042474,"eighty":48.464304,"marketCap":723536221},{"date":"2025-03-07","current":1.287534,"twenty":11.27329,"median":19.867491,"eighty":48.464304,"marketCap":684741350},{"date":"2025-03-14","current":1.248099,"twenty":11.172328,"median":19.867235,"eighty":48.464304,"marketCap":663769180},{"date":"2025-03-21","current":1.261901,"twenty":11.161297,"median":19.867235,"eighty":48.464304,"marketCap":671109440},{"date":"2025-03-28","current":1.258944,"twenty":11.155562,"median":19.867235,"eighty":48.464304,"marketCap":669536527},{"date":"2025-04-04","current":1.190919,"twenty":11.155562,"median":19.867235,"eighty":48.464304,"marketCap":633359534},{"date":"2025-04-11","current":1.122895,"twenty":11.140266,"median":19.79217,"eighty":48.464304,"marketCap":597182540},{"date":"2025-04-17","current":1.148527,"twenty":11.117799,"median":19.79217,"eighty":48.464304,"marketCap":610814451},{"date":"2025-04-25","current":1.17547,"twenty":11.123737,"median":19.867235,"eighty":48.464304,"marketCap":625143243},{"date":"2025-05-02","current":1.17547,"twenty":11.111923,"median":19.867235,"eighty":48.464304,"marketCap":625143243},{"date":"2025-05-09","current":1.131612,"twenty":11.111923,"median":19.867235,"eighty":48.464304,"marketCap":631961020},{"date":"2025-05-16","current":1.159785,"twenty":11.111923,"median":19.867235,"eighty":48.464304,"marketCap":647694490},{"date":"2025-05-23","current":1.103439,"twenty":11.111122,"median":19.867235,"eighty":48.464304,"marketCap":616227551},{"date":"2025-05-30","current":1.125977,"twenty":11.105833,"median":19.867235,"eighty":48.464304,"marketCap":628814327},{"date":"2025-06-06","current":1.094987,"twenty":11.039005,"median":19.867235,"eighty":48.464304,"marketCap":611507510},{"date":"2025-06-13","current":1.115647,"twenty":10.945567,"median":19.867235,"eighty":48.464304,"marketCap":623045388}],"updateTime":1750136526574}}}